Continuous venous infusion of vinblastine in metastatic breast cancer

Paolo Pronzalo, Paola Queirolo, Maria Giuseppina Vidili, Domenico Amoroso, Gianfdippo Berlelli, Mario Roberto Sertoli, Riccardo Rosso

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

In 19 patients with advanced pretreated breast cancer, vinblastine was administered by continuous venous infusion (2 mg/m2/24 h for 120 h every 3 weeks), using a totally implanted venous access and a portable pump. A total of 55 courses were given. Five objective responses were observed. Drug-related toxicity consisted mainly of leukopenia (4 patients), fever (4 patients) and nausea and vomiting (3 patients). Catheter-related toxicity was observed in 4 patients (21%) and consisted of infection of the skin pocket in 1 patient and dislodging of the needle with drug extravasation in 3 patients.

Original languageEnglish
Pages (from-to)146-149
Number of pages4
JournalChemotherapy
Volume37
Issue number2
DOIs
Publication statusPublished - 1991

Fingerprint

Vinblastine
Breast Neoplasms
Leukopenia
Drug-Related Side Effects and Adverse Reactions
Nausea
Needles
Vomiting
Fever
Catheters
Skin
Infection
Pharmaceutical Preparations

Keywords

  • Breast cancer
  • Continuous-infusion chemotherapy
  • Vinblastine

ASJC Scopus subject areas

  • Infectious Diseases
  • Oncology
  • Pharmacology (medical)
  • Drug Discovery
  • Pharmacology

Cite this

Pronzalo, P., Queirolo, P., Vidili, M. G., Amoroso, D., Berlelli, G., Sertoli, M. R., & Rosso, R. (1991). Continuous venous infusion of vinblastine in metastatic breast cancer. Chemotherapy, 37(2), 146-149. https://doi.org/10.1159/000238847

Continuous venous infusion of vinblastine in metastatic breast cancer. / Pronzalo, Paolo; Queirolo, Paola; Vidili, Maria Giuseppina; Amoroso, Domenico; Berlelli, Gianfdippo; Sertoli, Mario Roberto; Rosso, Riccardo.

In: Chemotherapy, Vol. 37, No. 2, 1991, p. 146-149.

Research output: Contribution to journalArticle

Pronzalo, P, Queirolo, P, Vidili, MG, Amoroso, D, Berlelli, G, Sertoli, MR & Rosso, R 1991, 'Continuous venous infusion of vinblastine in metastatic breast cancer', Chemotherapy, vol. 37, no. 2, pp. 146-149. https://doi.org/10.1159/000238847
Pronzalo, Paolo ; Queirolo, Paola ; Vidili, Maria Giuseppina ; Amoroso, Domenico ; Berlelli, Gianfdippo ; Sertoli, Mario Roberto ; Rosso, Riccardo. / Continuous venous infusion of vinblastine in metastatic breast cancer. In: Chemotherapy. 1991 ; Vol. 37, No. 2. pp. 146-149.
@article{bac421cb54344e63ae68af1a98b95239,
title = "Continuous venous infusion of vinblastine in metastatic breast cancer",
abstract = "In 19 patients with advanced pretreated breast cancer, vinblastine was administered by continuous venous infusion (2 mg/m2/24 h for 120 h every 3 weeks), using a totally implanted venous access and a portable pump. A total of 55 courses were given. Five objective responses were observed. Drug-related toxicity consisted mainly of leukopenia (4 patients), fever (4 patients) and nausea and vomiting (3 patients). Catheter-related toxicity was observed in 4 patients (21{\%}) and consisted of infection of the skin pocket in 1 patient and dislodging of the needle with drug extravasation in 3 patients.",
keywords = "Breast cancer, Continuous-infusion chemotherapy, Vinblastine",
author = "Paolo Pronzalo and Paola Queirolo and Vidili, {Maria Giuseppina} and Domenico Amoroso and Gianfdippo Berlelli and Sertoli, {Mario Roberto} and Riccardo Rosso",
year = "1991",
doi = "10.1159/000238847",
language = "English",
volume = "37",
pages = "146--149",
journal = "Chemotherapy",
issn = "0009-3157",
publisher = "S. Karger AG",
number = "2",

}

TY - JOUR

T1 - Continuous venous infusion of vinblastine in metastatic breast cancer

AU - Pronzalo, Paolo

AU - Queirolo, Paola

AU - Vidili, Maria Giuseppina

AU - Amoroso, Domenico

AU - Berlelli, Gianfdippo

AU - Sertoli, Mario Roberto

AU - Rosso, Riccardo

PY - 1991

Y1 - 1991

N2 - In 19 patients with advanced pretreated breast cancer, vinblastine was administered by continuous venous infusion (2 mg/m2/24 h for 120 h every 3 weeks), using a totally implanted venous access and a portable pump. A total of 55 courses were given. Five objective responses were observed. Drug-related toxicity consisted mainly of leukopenia (4 patients), fever (4 patients) and nausea and vomiting (3 patients). Catheter-related toxicity was observed in 4 patients (21%) and consisted of infection of the skin pocket in 1 patient and dislodging of the needle with drug extravasation in 3 patients.

AB - In 19 patients with advanced pretreated breast cancer, vinblastine was administered by continuous venous infusion (2 mg/m2/24 h for 120 h every 3 weeks), using a totally implanted venous access and a portable pump. A total of 55 courses were given. Five objective responses were observed. Drug-related toxicity consisted mainly of leukopenia (4 patients), fever (4 patients) and nausea and vomiting (3 patients). Catheter-related toxicity was observed in 4 patients (21%) and consisted of infection of the skin pocket in 1 patient and dislodging of the needle with drug extravasation in 3 patients.

KW - Breast cancer

KW - Continuous-infusion chemotherapy

KW - Vinblastine

UR - http://www.scopus.com/inward/record.url?scp=0025963779&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025963779&partnerID=8YFLogxK

U2 - 10.1159/000238847

DO - 10.1159/000238847

M3 - Article

C2 - 2032471

AN - SCOPUS:0025963779

VL - 37

SP - 146

EP - 149

JO - Chemotherapy

JF - Chemotherapy

SN - 0009-3157

IS - 2

ER -